Lynne M. Kerr

Lynne M. Kerr, MD, PhD

Languages spoken: English

Academic Information

Departments Emeritus - Pediatrics

Divisions: Neurology

Research Interests

  • Headache Disorders
  • Migraine Headaches
  • Quality Improvement

Dr. Kerr received her medical degree from the University of Utah School of Medicine after receiving her PhD in neurophysiology from the University of Virginia. She then completed her Pediatric and Neurology (Child/Adolescent) residencies at the University of Utah. She has been a physician at Shriners Hospitals for Children in Salt Lake City and the University of Utah Health Sciences Center in the Division of Pediatric Neurology. She is currently a Professor Emeritus at the University of Utah.

She was a Professor of Pediatrics at the University of Utah in the Division of Pediatric Neurology at Primary Children´s Hospital. She is very interested in helping families of children with special health care needs negotiate primary and subspecialty care. She was a Co-director of the Headache Clinic at Primary Children's Hospital and the Neuromuscular Clinic at Shriner's Hospital. She is on the Clinical and Scientific Advisory Boards of the Board of Directors of the Cornelia de Lange Syndrome Foundation. She has been a writer for 15 years for the Medical Home Portal (medicalhomeportal.org).

Education History

Residency University of Utah School of Medicine
 Resident
Residency University of Utah School of Medicine
 Resident
Internship University of Utah School of Medicine
 Intern
Professional Medical University of Utah Hospital School of Medicine
 MD
Postdoctoral Fellowship University of Utah
 Postdoctoral Fellow
Doctoral Training University of Virginia
 PhD
Undergraduate Yale University
 BA
Undergraduate Mount Holyoke College

Selected Publications

Journal Article

  1. MacWilliams BA, Carroll KL, Stotts AK, Kerr LM, Schwartz MH (2022). Discrimination between hereditary spastic paraplegia and cerebral palsy based on gait analysis data: A machine learning approach. Gait Posture, 98, 34-38. (Read full article)
  2. Pablo MJ, Pamplona P, Haddad M, Benavente I, Latorre-Pellicer A, Arnedo M, Trujillano L, Bueno-Lozano G, Kerr LM, Huisman SA, Kaiser FJ, Ramos F, Kline AD, Pie J, Puisac B (2021). High rate of autonomic neuropathy in Cornelia de Lange Syndrome. Orphanet J Rare Dis, 16(1), 458. (Read full article)
  3. Winder MM, Marietta J, Kerr LM, Puchalski MD, Zhang C, Ware AL, Cowley CG (2021). Reducing Unnecessary Diagnostic Testing in Pediatric Syncope: A Quality Improvement Initiative. Pediatr Cardiol, 42(4), 942-950. (Read full article)
  4. Kline AD, Moss JF, Selicorni A, Bisgaard AM, Deardorff MA, Gillett PM, Ishman SL, Kerr LM, Levin AV, Mulder PA, Ramos FJ, Wierzba J, Ajmone PF, Axtell D, Blagowidow N, Cereda A, Costantino A, Cormier-Daire V, FitzPatrick D, Grados M, Groves L, Guthrie W, Huisman S, Kaiser FJ, Koekkoek G, Levis M, Mariani M, McCleery JP, Menke LA, Metrena A, OConnor J, Oliver C, Pie J, Piening S, Potter CJ, Quaglio AL, Redeker E, Richman D, Rigamonti C, Shi A, Tmer Z, Van Balkom IDC, Hennekam RC (2018). Diagnosis and management of Cornelia de Lange syndrome: first international consensus statement. Nat Rev Genet, 19(10), 649-666.
  5. Kline AD, Moss JF, Selicorni A, Bisgaard AM, Deardorff MA, Gillett PM, Ishman SL, Kerr LM, Levin AV, Mulder PA, Ramos FJ, Wierzba J, Ajmone PF, Axtell D, Blagowidow N, Cereda A, Costantino A, Cormier-Daire V, FitzPatrick D, Grados M, Groves L, Guthrie W, Huisman S, Kaiser FJ, Koekkoek G, Levis M, Mariani M, McCleery JP, Menke LA, Metrena A, OConnor J, Oliver C, Pie J, Piening S, Potter CJ, Quaglio AL, Redeker E, Richman D, Rigamonti C, Shi A, Tmer Z, Van Balkom IDC, Hennekam RC (2018). Diagnosis and management of Cornelia de Lange syndrome: first international consensus statement. Nat Rev Genet, 19(10), 649-666. (Read full article)
  6. Nelson GR, Bale JF, Kerr LM (2017). Outcome and Cost of Inpatient Hospitalization for Intravenous Dihydroergotamine Treatment of Refractory Pediatric Headache. Pediatr Neurol, 66, 76-81. (Read full article)
  7. Powers SW, Coffey CS, Chamberlin LA, Ecklund DJ, Klingner EA, Yankey JW, Korbee LL, Porter LL, Hershey AD, CHAMP Investigators (5/11/2017). Trial of Amitriptyline, Topiramate, and Placebo for Pediatric Migraine. N Engl J Med, 376(2), 115-124.
  8. Nelson GR, Filloux FM, Kerr LM (2016). Educational Intervention Improves Compliance With AAN Guidelines for Return Epilepsy Visits: A Quality Improvement Project. J Child Neurol, 31(11), 1320-3. (Read full article)
  9. Roundy LM, Filloux FM, Kerr L, Rimer A, Bonkowsky JL (2015). Seizure Action Plans Do Not Reduce Health Care Utilization in Pediatric Epilepsy Patients. J Child Neurol, 31(4), 433-8. (Read full article)
  10. Roundy, LM, Filloux, F, Kerr, LM, Rimer, A, Bonkowsky, JL (8/5/2015). Seizure action plans do not reduce health care utilization in pediatric epilepsy patients. J Child Neurol.
  11. Hesse T, Holmes LG, Kennedy-Overfelt V, Kerr LM, Giles LL (2015). Mindfulness-Based Intervention for Adolescents with Recurrent Headaches: A Pilot Feasibility Study. Evid Based Complement Alternat Med, 2015, 508958. (Read full article)
  12. Barclay JL, Nelson CN, Ishikawa M, Murray LA, Kerr LM, McPhee TR, Powell EE, Waters MJ (2011). GH-dependent STAT5 signaling plays an important role in hepatic lipid metabolism. Endocrinology, 152(1), 181-92. (Read full article)
  13. Norlin C, Kerr LM, Rocha RA (2009). Using clinical questions to structure the content of a web-based information resource for primary care physicians. AMIA Annu Symp Proc, 2009, 482-6. (Read full article)
  14. Dent, KM, Dunn, DM, von Niederhausen, AC, Aoyagi, AT, Kerr, LM, Bromberg, MB, Hart, KJ, Tuohy, White, S, den Dunnen, JT, Weiss, RB, and Flanigan, KM (2005). Improved molecular diagnosis of dystrophinopathies in an unselected clinical cohort. Am J Med Genet, 134A(3), 295-298..
  15. Flanigan, KM, Kerr, LM, Bromberg, MB, Leonard, C, Tsuruda, J, Zhang, P, Gonzalez-Gomez, I, Cohn, R, Campbell, KP, Leppert, M (2000). Congenital muscular dystrophy with rigid spine syndrome: A clinical, pathological, radiological, and genetic study. Ann Neurol, 47(2), 152-161.
  16. Kerr LM, Anderson DM, Thompson JA, Lyver SM, Call GK (1993). Ischemic stroke in the young: evaluation and age comparison of patients six months to thirty-nine years. J Child Neurol, 8(3), 266-70. (Read full article)
  17. Kerr LM, Unis AS, Wamsley JK (1988). Comparison of the density and distribution of brain D-1 and D-2 dopamine receptors in Buffalo vs. Fischer 344 rats. Pharmacol Biochem Behav, 30(2), 325-30. (Read full article)
  18. Kerr LM, Filloux F, Olivera BM, Jackson H, Wamsley JK (1988). Autoradiographic localization of calcium channels with [125I]omega-conotoxin in rat brain. Eur J Pharmacol, 146(1), 181-3. (Read full article)
  19. Cruz LJ, Gray WR, Olivera BM, Zeikus RD, Kerr L, Yoshikami D, Moczydlowski E (1985). Conus geographus toxins that discriminate between neuronal and muscle sodium channels. J Biol Chem, 260(16), 9280-8. (Read full article)
  20. KerrLMYoshikamiD (1984). A venom peptide with a novel presynaptic blocking action. Nature, 308(5956), 282-284.
  21. Kerr LM, Sperelakis N (1983). Ca2+-dependent slow action potentials in normal and dystrophic mouse skeletal muscle. Am J Physiol, 245(5 Pt 1), C415-22. (Read full article)
  22. Kerr LM, Sperelakis N (1983). Effects of pH on membrane resistance in normal and dystrophic mouse skeletal muscle fibers. Exp Neurol, 82(1), 203-14. (Read full article)
  23. Kerr LM, Sperelakis N (1983). Membrane alterations in skeletal muscle fibers of dystrophic mice. Muscle Nerve, 6(1), 3-13. (Read full article)
  24. Kerr LM, Sperelakis N (1982). Effect of the calcium antagonists bepridil (CERM-1978) and verapamil on Ca++-dependent slow action potentials in frog skeletal muscle. J Pharmacol Exp Ther, 222(1), 80-6. (Read full article)
  25. Kerr LM, Ostapoff EM, Rubel EW (1979). Influence of acoustic experience on the ontogeny of frequency generalization gradients in the chicken. J Exp Psychol Anim Behav Process, 5(2), 97-115. (Read full article)

Book Chapter

  1. Cristina Trandafir, MD, Tara Newcomb, MS, CGC, and Lynne Kerr, MD, PhD (). New Onset Seizures in an Infant. In Dr. Ethylin Jabs and Dr Antonie Kline.   (Eds.), Genomics in the Clinic. Elsevier.
  2. Tara Newcomb, MS, CGC, Russell Butterfield, MD, and Lynne Kerr, MD, PhD (). Club Feet and Lack of Facial Expression. In Dr. Ethylin Jabs and Dr Antonie Kline (Eds.), Genomics in the Clinic. Elsevier.
  3. Lynne M Kerr, MD, PhD, Tara Newcomb, MS, CGC, and Russel Butterfield, MD (). Abnormal Gait in a Toddler. In Dr. Ethylin Jabs and Dr Antonie Kline.   (Eds.), Genomics in the Clinic.
  4. Lynne M Kerr, Sue E Huether, and Richard A Sugerman (2016). Structure and Function of the Neurologic System. In Kathryn L McCance; Sue E Huether (Ed.), Understanding Pathophysiology (6th Edition, pp. 316-345). London: Elsevier Health Sciences.
  5. Kerr LM, Huether SE, Narayanan V (2016). Alterations of neurologic function in children. In Huether SE, McCance KL (Eds.), Understanding Pathophysiology (6th edition, pp. 436-453). St Louis, Missouri: Elsevier.
  6. Carbone, P, Kerr, LM, and Reynolds, A (2014). Management of general medical conditions. In Matson, J.L., Sturney, P., Tarbox, J., Dixon, D.R. (Eds.), Handbook of Early Intervention for Autism Spectrum Disorders (pp. 533-562). New York: Spinger Publications.
  7. Carroll, K, Kerr, LM, McCance, KL (2012). Alterations of musculoskeletal conditions in children. In Huether, S.E., and McCance, K.L. (Eds.), Understanding Pathophysiology (6th). St Louis, Missouri: Elsevier.

Case Report

  1. Kerr, LM, and Filloux, F (1993). Cerebral infarction as a remote complication of childhood Hemophilus Influenzae Meningitis. West J Med, 157(2`), 179-181.

Abstract

  1. Kline AD, Krantz ID, Deardorff MA, Shirahige K, Dorsett D, Gerton JL, Wu M, Mehta D, Mills JA, Carrico CS, Noon S, Herrera PS, Horsfield JA, Bettale C, Morgan J, Huisman SA, Moss J, McCleery J, Grados M, Hansen BD, Srivastava S, Taylor-Snell E, Kerr LM, Katz O, Calof AL, Musio A, Egense A, Haaland RE (05/2017). Cornelia de Lange syndrome and molecular implications of the cohesin complex: Abstracts from the 7th biennial scientific and educational symposium 2016. [Abstract]. Am J Med Genet A, 173(5), 1172-1185.
  2. Kerr, LM, Jones, A, Kline, AD, and Fischer, PR (11/2015). COMPASS-31 Questionnaire Screening in Individuals with Cornelia de Lange Syndrome [Abstract]. Autonomic Neuroscience, 192(Special), 134.
  3. Norlin, C, Kerr, LM, and Rocha, R (2009). The MedHomePortal - Developing Content Around Clinical Questions and Using Clinical Questions to Guide and Index Content of a Web-based Medical Home Information Resource [Abstract]. AMIA Annu Symp Proc, 14, 482-486.
  4. Norlin, C, Kerr, LM, and Rocha, R (2009). Using clinical questions to structure the content of a web-based information resource for primary care physicians [Abstract]. AMIA Annual Symposium Proceedings, 14, 482-486.

Other

  1. Kline AD, Krantz ID, Deardorff MA, Shirahige K, Dorsett D, Gerton JL, Wu M, Mehta D, Mills JA, Carrico CS, Noon S, Herrera PS, Horsfield JA, Bettale C, Morgan J, Huisman SA, Moss J, McCleery J, Grados M, Hansen BD, Srivastava S, Taylor-Snell E, Kerr LM, Katz O, Calof AL, Musio A, Egense A, Haaland RE (2017). Cornelia de Lange syndrome and molecular implications of the cohesin complex: Abstracts from the 7th biennial scientific and educational symposium 2016. Am J Med Genet A (173(5), pp. 1172-1185). United States. (Read full article)